日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer

辅助化疗与II期结肠癌患者生存率的提高相关。

Casadaban, Leigh; Rauscher, Garth; Aklilu, Mebea; Villenes, Dana; Freels, Sally; Maker, Ajay V

A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study

化疗期间实施的简短瑜伽干预:一项随机对照试点研究

Sohl, Stephanie J; Danhauer, Suzanne C; Birdee, Gurjeet S; Nicklas, Barbara J; Yacoub, George; Aklilu, Mebea; Avis, Nancy E

[Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer]

[副肿瘤性白细胞增多症和血小板增多症作为非小细胞肺癌的预后生物标志物]

Boddu, Prajwal; Villlines, Dana; Aklilu, Mebea

Alliance of Independent Academic Medical Centers Outstanding Resident Poster: Effect of Ethnic Disparities on the Outcome of Stage III Colon Cancer Patients

独立学术医疗中心联盟优秀住院医师海报:种族差异对 III 期结肠癌患者预后的影响

Sequera, Carlos; Mebea, Aklilu; Rajput, Punam

Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer

一项II期临床试验,研究在细胞减灭术和腹腔热灌注化疗后,辅助口服沙利度胺治疗结直肠癌/阑尾癌腹膜转移的疗效。

Shen, Perry; Thomas, Christopher R; Fenstermaker, Joyce; Aklilu, Mebea; McCoy, Thomas P; Levine, Edward A

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

一项针对胰腺腺癌患者的改良癌胚抗原(CEA)肽(CAP1-6D)/蒙塔尼德/GM-CSF疫苗的随机I期试点研究

Geynisman, Daniel M; Zha, Yuanyuan; Kunnavakkam, Rangesh; Aklilu, Mebea; Catenacci, Daniel Vt; Polite, Blase N; Rosenbaum, Cara; Namakydoust, Azadeh; Karrison, Theodore; Gajewski, Thomas F; Kindler, Hedy L

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer

一项随机II期研究比较了用编码CEA和MUC1的痘病毒载体修饰的树突状细胞进行免疫治疗与用相同痘病毒载体加GM-CSF治疗切除转移性结直肠癌的疗效。

Morse, Michael A; Niedzwiecki, Donna; Marshall, John L; Garrett, Christopher; Chang, David Z; Aklilu, Mebea; Crocenzi, Todd S; Cole, David J; Dessureault, Sophie; Hobeika, Amy C; Osada, Takuya; Onaitis, Mark; Clary, Bryan M; Hsu, David; Devi, Gayathri R; Bulusu, Anuradha; Annechiarico, Robert P; Chadaram, Vijaya; Clay, Timothy M; Lyerly, H Kim

A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma

一项针对不可切除胰腺癌患者的I期临床试验,采用每周一次奥沙利铂联合吉西他滨治疗,随后在放疗期间采用奥沙利铂、吉西他滨和厄洛替尼联合治疗。

Raftery, Laura; Tepper, Joel E; Goldberg, Richard M; Blackstock, A William; Aklilu, Mebea; Bernard, Stephen A; Ivanova, Anastasia; Davies, Janine M; O'Neil, Bert H

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery

靶向药物对接受伽玛刀手术治疗的肾细胞癌脑转移患者预后的影响

Cochran, D Clay; Chan, Michael D; Aklilu, Mebea; Lovato, James F; Alphonse, Natalie K; Bourland, J Daniel; Urbanic, James J; McMullen, Kevin P; Shaw, Edward G; Tatter, Stephen B; Ellis, Thomas L

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas

期生物标志物研究结果的逆向翻译将血管紧张素-(1-7) 的活性与血管肉瘤中缺氧诱导因子-1α 的抑制联系起来

W Jeffrey Petty, Mebea Aklilu, Victor A Varela, James Lovato, Paul D Savage, Antonius A Miller